2 completed, 1 suspended, 1 terminated, 1 withdrawn. 5 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Suspended 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 5 | Completed 2, Suspended 1, Terminated 1, Withdrawn 1 |
Follow contrast agent BR1: new trials by email Literature Review of contrast agent BR1 trials Research Report on contrast agent BR1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) NaviFUS System, Lumason, Bevacizumab - Glioblastoma Multiforme, Glioblastoma | Phase 1 / Phase 2 | Suspended | NaviFUS Corporation | 10 | 2024-10-22 | 2026-09-09 |
| Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study) Lumason - Abdominal Injury | Phase 1 / Phase 2 | Completed | David Mooney | 68 | 2021-05-10 | 2025-10-03 |
| Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer SonoVue, Focused Ultrasound - Colorectal Neoplasms, Breast Neoplasms | Phase 1 / Phase 2 | Completed | St. Olavs Hospital | 17 | 2018-11-12 | 2023-01-19 |
| Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children Lumason - Abdominal Injury | Phase 1 / Phase 2 | Terminated | David Mooney | 74 | 2017-11-01 | 2021-06-11 |
| Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE) SonoVue, Optison - Coronary Artery Disease | Phase 1 / Phase 2 | Withdrawn | University Hospital, Basel, Switzerland | 2006-08-01 | 2015-03-25 |
Abdominal Injuries (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Coronary Artery Disease (1) · Glioblastoma (1) · Glioma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Nerve Tissue (1)
David Mooney (2) · NaviFUS Corporation (1) · St. Olavs Hospital (1) · University Hospital, Basel, Switzerland (1)
United States (3) · Norway (1)
David Mooney, MD, MPH (2) · Arne Solberg, PhD, MD (1) · Manfred D Seeberger, Prof. Dr. (1)
2018 (1)